anonymous
Guest
anonymous
Guest
The company is going to have to hire dumber and dumber people to push medicine. People who think when marketing team changes strategies from diabetes to weight loss, mechanism of action of medicine no longer has any effect on healthy pancreas. Let’s just focus on feeling full and eating less. Pancreas not an issue. What about unstudied effects these laboratory hormones have on other organs in body. Why does the national institute of health want to study papillary and medullary thyroid cancer with these synthetic hormones? These stupid people going to interact with highly academic physicians? Maybe this is why sales were off last quarter in spite of plenty of supply.